Fatal Pulmonary Embolism Secondary to Heparin‐Induced Thrombocytopenia in Hemodialysis: A Case Study
Hemodialysis International · 2026
DOI: 10.1111/hdi.70011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hemodialysis International, 2026. Verfasst von Yan Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Pulmonary Embolism, Renal Dialysis, Thrombocytopenia, Heparin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Peking University Shenzhen Hospital Scientific Research Fund, Shenzhen Clinical Research Center for Urology and Nephrology.
Abstract (Originalsprache)
Background
Heparin and low‐molecular‐weight heparin (LMWH) are first‐line anticoagulants in hemodialysis but may trigger heparin‐induced thrombocytopenia (HIT), a severe immune‐mediated complication. Despite its clinical significance, HIT is often misdiagnosed early, increasing thromboembolic risks and mortality. Case Report We present a case of a 61‐year‐old male patient who developed HIT during initial hemodialysis. The patient exhibited recurrent catheter thrombosis, intermuscular venous thrombosis in the lower extremities, and progressive thrombocytopenia following LMWH administration during dialysis. The diagnosis was confirmed by IgG‐specific anti‐PF4/heparin antibody testing. Shortly after the last dialysis session, the patient developed acute dyspnea and chest pain. Computed tomography angiography of the chest revealed pulmonary embolism. Despite aggressive intervention, the patient's condition deteriorated rapidly, with platelet counts dropping to 5 × 10 9 /L, culminating in a fatal outcome.
Conclusion
The combination of dialysis catheter thrombosis and declining platelet counts constitutes an essential early diagnostic clue for HIT in hemodialysis patients, the recognition of which could prevent fatal thromboembolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Peking University Shenzhen Hospital, Shenzhen, China.
- Shenzhen Clinical Research Center for Urology and Nephrology, Shenzhen, China.
ORCID-Profile: Yan Yang
Förderung
- Peking University Shenzhen Hospital Scientific Research Fund
- Shenzhen Clinical Research Center for Urology and Nephrology
Zitieren
APA
Yang, Y., Xiong, Z., He, Y., Wang, A., Huang, X., & Liang, W. (2026). Fatal Pulmonary Embolism Secondary to Heparin‐Induced Thrombocytopenia in Hemodialysis: A Case Study. Hemodialysis International. https://doi.org/10.1111/hdi.70011
Vancouver
Yang Y, Xiong Z, He Y, Wang A, Huang X, Liang W. Fatal Pulmonary Embolism Secondary to Heparin‐Induced Thrombocytopenia in Hemodialysis: A Case Study. Hemodialysis International. 2026. doi:10.1111/hdi.70011
BibTeX
@article{Yang2026,
author = {Yang, Yan and Xiong, Zibo and He, Yingying and Wang, Aihong and Huang, Xiaoyan and Liang, Wei},
title = {Fatal Pulmonary Embolism Secondary to Heparin‐Induced Thrombocytopenia in Hemodialysis: A Case Study},
journal = {Hemodialysis International},
year = {2026},
doi = {10.1111/hdi.70011}
}
EUVIMED